269 related articles for article (PubMed ID: 37954979)
1. Targeting hedgehog-driven mechanisms of drug-resistant cancers.
Miller JS; Bennett NE; Rhoades JA
Front Mol Biosci; 2023; 10():1286090. PubMed ID: 37954979
[TBL] [Abstract][Full Text] [Related]
2. Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened.
Pietrobono S; Gagliardi S; Stecca B
Front Genet; 2019; 10():556. PubMed ID: 31244888
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter.
Ding J; Zhou XT; Zou HY; Wu J
Lab Invest; 2017 Jul; 97(7):819-832. PubMed ID: 28414325
[TBL] [Abstract][Full Text] [Related]
4. Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition.
Peer E; Aichberger SK; Vilotic F; Gruber W; Parigger T; Grund-Gröschke S; Elmer DP; Rathje F; Ramspacher A; Zaja M; Michel S; Hamm S; Aberger F
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439381
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance.
Nguyen NM; Cho J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163655
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications.
Grund-Gröschke S; Stockmaier G; Aberger F
Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932
[TBL] [Abstract][Full Text] [Related]
8. The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Bhateja P; Cherian M; Majumder S; Ramaswamy B
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31394751
[TBL] [Abstract][Full Text] [Related]
9. Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
Pietrobono S; Gaudio E; Gagliardi S; Zitani M; Carrassa L; Migliorini F; Petricci E; Manetti F; Makukhin N; Bond AG; Paradise BD; Ciulli A; Fernandez-Zapico ME; Bertoni F; Stecca B
Oncogene; 2021 Jun; 40(22):3799-3814. PubMed ID: 33958721
[TBL] [Abstract][Full Text] [Related]
10. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
[TBL] [Abstract][Full Text] [Related]
11. Nonclassical hedgehog-GLI signaling and its clinical implications.
Shevde LA; Samant RS
Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
[TBL] [Abstract][Full Text] [Related]
12. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
13. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1.
Götschel F; Berg D; Gruber W; Bender C; Eberl M; Friedel M; Sonntag J; Rüngeler E; Hache H; Wierling C; Nietfeld W; Lehrach H; Frischauf A; Schwartz-Albiez R; Aberger F; Korf U
PLoS One; 2013; 8(6):e65403. PubMed ID: 23762360
[TBL] [Abstract][Full Text] [Related]
14. CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists.
Liu F; Jiang W; Sui Y; Meng W; Hou L; Li T; Li M; Zhang L; Mo J; Wang J; Zhao Y; Zhang L; Ma J; Tang Y
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12986-12995. PubMed ID: 31182587
[TBL] [Abstract][Full Text] [Related]
15. Interference with SMO increases chemotherapy drug sensitivity of A2780/DDP cells by inhibiting the Hh/Gli signaling pathway.
Ma S; Liu D; Tan W; Du B; Liu W; Li W; Jiao Y
J Cell Biochem; 2020 Jun; 121(5-6):3256-3265. PubMed ID: 31904145
[TBL] [Abstract][Full Text] [Related]
16. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance.
Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F
Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107
[TBL] [Abstract][Full Text] [Related]
17. Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma.
Liu X; Zhang Y; Li Y; Wang J; Ding H; Huang W; Ding C; Liu H; Tan W; Zhang A
Acta Pharm Sin B; 2021 Feb; 11(2):488-504. PubMed ID: 33643826
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.
Aberger F; Hutterer E; Sternberg C; Del Burgo PJ; Hartmann TN
Cell Commun Signal; 2017 Jan; 15(1):8. PubMed ID: 28122581
[TBL] [Abstract][Full Text] [Related]
19. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog signalling: emerging evidence for non-canonical pathways.
Jenkins D
Cell Signal; 2009 Jul; 21(7):1023-34. PubMed ID: 19399989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
